ATE366797T1 - Verfharen zur konservierung von viren und mycoplasma - Google Patents

Verfharen zur konservierung von viren und mycoplasma

Info

Publication number
ATE366797T1
ATE366797T1 AT00927438T AT00927438T ATE366797T1 AT E366797 T1 ATE366797 T1 AT E366797T1 AT 00927438 T AT00927438 T AT 00927438T AT 00927438 T AT00927438 T AT 00927438T AT E366797 T1 ATE366797 T1 AT E366797T1
Authority
AT
Austria
Prior art keywords
mycoplasma
viruses
preserving
preserving viruses
Prior art date
Application number
AT00927438T
Other languages
English (en)
Inventor
Eric Edward Worrall
Original Assignee
Anhydro Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909999.6A external-priority patent/GB9909999D0/en
Priority claimed from GBGB9926698.3A external-priority patent/GB9926698D0/en
Application filed by Anhydro Ltd filed Critical Anhydro Ltd
Application granted granted Critical
Publication of ATE366797T1 publication Critical patent/ATE366797T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT00927438T 1999-05-04 2000-05-03 Verfharen zur konservierung von viren und mycoplasma ATE366797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909999.6A GB9909999D0 (en) 1999-05-04 1999-05-04 Protection of sensitive viruses and bacteria in vaccines
GBGB9926698.3A GB9926698D0 (en) 1999-11-12 1999-11-12 Method for the preserving of viruses, bacteria and biomolecules

Publications (1)

Publication Number Publication Date
ATE366797T1 true ATE366797T1 (de) 2007-08-15

Family

ID=26315490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927438T ATE366797T1 (de) 1999-05-04 2000-05-03 Verfharen zur konservierung von viren und mycoplasma

Country Status (18)

Country Link
US (1) US6664099B1 (de)
EP (1) EP1175486B1 (de)
JP (1) JP2002542815A (de)
KR (1) KR100616195B1 (de)
CN (1) CN1433465A (de)
AP (1) AP1521A (de)
AT (1) ATE366797T1 (de)
AU (1) AU776982B2 (de)
BR (1) BR0010249A (de)
CA (1) CA2365277A1 (de)
DE (1) DE60035497T2 (de)
DK (1) DK1175486T3 (de)
EA (1) EA004131B1 (de)
ES (1) ES2290028T3 (de)
MX (1) MXPA01011145A (de)
OA (1) OA11936A (de)
TR (1) TR200103149T2 (de)
WO (1) WO2000066710A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
WO2005113147A2 (en) 2004-04-08 2005-12-01 Biomatrica, Inc. Integration of sample storage and sample management for life science
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
JP5285617B2 (ja) * 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
HUE031617T2 (en) 2007-04-06 2017-07-28 Takeda Vaccines Inc Methods and compositions for live attenuated viruses
JP2010534622A (ja) 2007-07-26 2010-11-11 サノフィ パストゥール リミテッド 抗原−アジュバント組成物および方法
DE102007036695A1 (de) * 2007-08-03 2009-02-05 Ab Skf Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager
EP3266448B1 (de) 2009-03-27 2022-02-16 Intervet International B.V. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
SG176253A1 (en) 2009-05-26 2011-12-29 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
EP2598661B1 (de) 2010-07-26 2017-09-27 Biomatrica, INC. Zusammensetzungen zur stabilisierung von dna, rna und proteinen in speichel- und anderen biologischen proben während des transports und der lagerung bei umgebungstemperaturen
US9376709B2 (en) 2010-07-26 2016-06-28 Biomatrica, Inc. Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
CL2011001984A1 (es) 2010-08-13 2012-06-29 Advanced Bionutrition Corp Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
EP2697368B1 (de) 2011-04-15 2019-06-05 Genelux Corporation Klonale stämme von abgeschwächten vaccinia-viren und verwendungsverfahren davon
WO2014055960A1 (en) 2012-10-05 2014-04-10 Genelux Corporation Energy absorbing-based diagnostic and therapeutic methods employing nucleic acid molecules encoding chromophore-producing enzymes
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
WO2015103438A2 (en) 2014-01-02 2015-07-09 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
EP3328215B1 (de) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stabile trockene probiotische zusammensetzungen für spezielle diätverwendungen
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
ES2946184T3 (es) 2015-12-08 2023-07-13 Biomatrica Inc Reducción de la velocidad de eritrosedimentación
CN105462840A (zh) * 2015-12-10 2016-04-06 浙江卫信生物药业有限公司 一种口腔支原体的活体冻干体的制备方法
EP4551240A1 (de) 2022-07-08 2025-05-14 Viromissile, Inc. Onkolytische vacciniaviren und rekombinante viren sowie verfahren zur verwendung davon
CN116585724A (zh) * 2023-05-25 2023-08-15 广州和实生物技术有限公司 玻璃化真空干燥试剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
CN1245957C (zh) * 1995-06-07 2006-03-22 廓德伦特控股剑桥有限公司 将物质稳定掺入干燥泡沫玻璃基质中的方法以及由此制得的组合物
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation

Also Published As

Publication number Publication date
WO2000066710A2 (en) 2000-11-09
BR0010249A (pt) 2002-02-13
AP1521A (en) 2005-12-22
CN1433465A (zh) 2003-07-30
EP1175486B1 (de) 2007-07-11
EA200101167A1 (ru) 2002-06-27
JP2002542815A (ja) 2002-12-17
WO2000066710A3 (en) 2001-02-08
AU4584400A (en) 2000-11-17
AP2001002335A0 (en) 2001-12-31
CA2365277A1 (en) 2000-11-09
MXPA01011145A (es) 2003-07-14
KR100616195B1 (ko) 2006-08-25
TR200103149T2 (tr) 2002-01-21
OA11936A (en) 2006-04-12
KR20020012201A (ko) 2002-02-15
DE60035497D1 (de) 2007-08-23
AU776982B2 (en) 2004-09-30
EP1175486A2 (de) 2002-01-30
EA004131B1 (ru) 2003-12-25
US6664099B1 (en) 2003-12-16
DE60035497T2 (de) 2007-10-31
DK1175486T3 (da) 2007-10-29
ES2290028T3 (es) 2008-02-16

Similar Documents

Publication Publication Date Title
DE60035497D1 (de) Verfharen zur konservierung von viren und mycoplasma
ATE311741T1 (de) Ernteverfahren und erntevorrichtung
DE69943396D1 (de) Insufflationsanordnung, fixierung und verfahren
DE60032654D1 (de) Vorrichtung zur Reinigung und Trocknung von Substraten
EP1405204A4 (de) Inhaltsverwaltungssystem und prozess
DE69933214D1 (de) Verfahren zur herstellung von waschbaren, trocknenden und elastischen gegenständen
DE69940804D1 (de) Verfahren und vorrichtung zur unterdrückung von abklingartefakten
DE60045817D1 (de) Methode und vorrichtung zur zufuhr von nahrungsmitteln
DE60029715D1 (de) Verfahren und anordnung zur verschleierung von rahmenausfall
EP1198271A4 (de) Geräte und methoden zur stimulationdes vagusnervs
DE69936953D1 (de) Verfahren und System zur Durchführung von statischen Initialisierung
DE69927529D1 (de) Methode und zusammensetzung zur entfernung von schwefelwasserstoff
DE59904772D1 (de) Vorrichtung zur übernahme und beförderung von gegenständen
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE60012138D1 (de) Gerät zur behandlung von fibrillation
DE60014928D1 (de) Retinoide zur behandlung von emphysem
DE69913050D1 (de) Sortierungssystem und Methode
DE69925482D1 (de) Verfahren, einrichtung und gerät zur authentifizierung
DE69936251D1 (de) Mittel zur vorbeugung und linderung der periodontose
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE60033759D1 (de) Destillationsapparat und Destillationsmethode
DE69900168D1 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
DE69915084D1 (de) Methode zur vermeidung oder verzögerung von katheterbedingter gefässrückbildung
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE19983200T1 (de) Vorrichtung zur Luftbehandlung von Produkten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1175486

Country of ref document: EP

REN Ceased due to non-payment of the annual fee